Financial Perspectives, Inc Abb Vie Inc. Transaction History

Financial Perspectives, Inc

$288 Billion
Q3 2024

A detailed history of Financial Perspectives, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Financial Perspectives, Inc holds 12,207 shares of ABBV stock, worth $2.14 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares

12,207

Previous 12,204 0.02%

Holding current value

$2.14 Million

Previous $2.09 Billion 15.16%

% of portfolio

0.84%

Previous 0.77%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$163.84 - $199.33 $491 - $597	3 Added 0.02%	12,207 $2.41 Billion
Q2 2024 Aug 09, 2024	BUY	$154.79 - $180.76 $464 - $542	3 Added 0.02%	12,204 $2.09 Billion
Q1 2024 Apr 19, 2024	SELL	$159.82 - $182.1 $799 - $910	-5 Reduced 0.04%	12,201 $2.22 Billion
Q4 2023 Feb 01, 2024	SELL	$137.6 - $154.97 $2,889 - $3,254	-21 Reduced 0.17%	12,206 $1.89 Billion
Q3 2023 Jan 09, 2024	BUY	$133.59 - $154.65 $14,828 - $17,166	111 Added 0.92%	12,227 $1.82 Billion
Q2 2023 Jan 09, 2024	BUY	$132.51 - $164.9 $2,517 - $3,133	19 Added 0.16%	12,116 $1.63 Billion
Q1 2023 Jan 09, 2024	SELL	$144.61 - $166.54 $26,463 - $30,476	-183 Reduced 1.49%	12,097 $1.93 Billion
Q4 2022 Jan 09, 2024	BUY	$138.31 - $165.87 $276 - $331	2 Added 0.02%	12,280 $1.98 Billion
Q3 2022 Jan 09, 2024	BUY	$134.21 - $153.93 $17,313 - $19,856	129 Added 1.06%	12,278 $1.65 Billion
Q2 2022 Jan 09, 2024	SELL	$137.62 - $174.96 $21,881 - $27,818	-159 Reduced 1.29%	12,149 $1.86 Billion
Q1 2022 Jan 09, 2024	BUY	$131.98 - $163.75 $36,294 - $45,031	275 Added 2.29%	12,308 $2 Billion
Q3 2021 Jan 09, 2024	BUY	$106.4 - $120.78 $9,895 - $11,232	93 Added 0.78%	12,033 $1.3 Billion
Q2 2021 Jan 09, 2024	SELL	$105.21 - $117.21 $135 Million - $150 Million	-1,280,207 Reduced 99.08%	11,940 $1.34 Billion
Q1 2021 Jan 09, 2024	BUY	$102.3 - $112.62 $131 Million - $144 Million	1,281,674 Added 12237.89%	1,292,147 $11.9 Million
Q4 2020 Jan 09, 2024	BUY	$80.49 - $108.67 $32,839 - $44,337	408 Added 4.05%	10,473 $1.12 Billion
Q3 2020 Jan 09, 2024	BUY	$85.91 - $100.83 $85 - $100	1 Added 0.01%	10,065 $882 Million
Q2 2020 Jan 09, 2024	BUY	$73.37 - $98.18 $2,788 - $3,730	38 Added 0.38%	10,064 $988 Million
Q1 2020 Jan 09, 2024	BUY	$64.5 - $97.79 $3,160 - $4,791	49 Added 0.49%	10,026 $764 Million
Q4 2019 Jan 09, 2024	BUY	$72.13 - $90.25 $719,641 - $900,424	9,977 New	9,977 $883 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Perspectives, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Perspectives, Inc with notifications on news.

Account

Financial Perspectives, Inc Abb Vie Inc. Transaction History